Towards derivation of a distinct signature permitting personalised treatment in prostate cancer

被引：0
|
作者：
Lamb, A. D. G. [1 ]
Sharma, N. L. [1 ]
Russell, R. [1 ]
Ramos-Montoya, A. [1 ]
Ross-Adams, H. [1 ]
Whittaker, H. [1 ]
Shaw, G. [1 ]
Wadhwa, K. [1 ]
Hori, S. [1 ]
Warren, A. [1 ]
Neal, D. E. [1 ]
机构：
[1] Addenbrookes Hosp, Cambridge, England
来源：
BRITISH JOURNAL OF SURGERY | 2013年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [21] Spatial transcriptomics reveals a distinct B cell signature in the dormant prostate cancer bone microenvironment
    Nasr, Mostafa M.
    Bishop, Ryan T.
    du Bois, Haley
    Li, Tao
    Frieling, Jeremy S.
    Lynch, Conor C.
    CANCER RESEARCH, 2024, 84 (22)
  • [22] A DISTINCT PLASMA LIPID SIGNATURE ASSOCIATED WITH POOR PROGNOSIS IN CASTRATION-RESISTANT PROSTATE CANCER
    Horvath, Lisa
    Lin, Hui-Ming
    Mahon, Kate
    Weir, Jacquelyn
    Mundra, Piyushkumar
    Spielman, Calan
    Briscoe, Karen
    Gurney, Howard
    Mallesara, Girish
    Marx, Gavin
    Stockler, Martin
    Parton, Robert
    Hoy, Andrew
    Daly, Roger
    Meikle, Peter
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 34 - 35
  • [23] A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer
    Lin, Hui-Ming
    Mahon, Kate L.
    Weir, Jacquelyn M.
    Mundra, Piyushkumar A.
    Spielman, Calan
    Briscoe, Karen
    Gurney, Howard
    Mallesara, Girish
    Marx, Gavin
    Stockler, Martin R.
    Parton, Robert G.
    Hoy, Andrew J.
    Daly, Roger J.
    Meikle, Peter J.
    Horvath, Lisa G.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (10) : 2112 - 2120
  • [24] Metabolic heterogeneity signature of primary treatment-naive prostate cancer
    Lin, Dong
    Ettinger, Susan L.
    Qu, Sifeng
    Xue, Hui
    Nabavi, Noushin
    Choi, Stephen Yiu Chuen
    Bell, Robert H.
    Mo, Fan
    Haegert, Anne M.
    Gout, Peter W.
    Fleshner, Neil
    Gleave, Martin E.
    Pollak, Michael
    Collins, Colin C.
    Wang, Yuzhuo
    ONCOTARGET, 2017, 8 (16) : 25928 - 25941
  • [25] Novel molecular radiobiology for personalised prostate cancer radiotherapy
    McDermott, N.
    Meunier, A.
    Jameson, T.
    Mansour, A.
    Haynes, C.
    Flores, A.
    O'Callaghan, A.
    Marignol, L.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S200 - S200
  • [26] Personalised treatment of head and neck cancer
    Keilholz, U.
    ONKOLOGIE, 2011, 34 : 203 - 204
  • [27] Personalised molecular radiotherapy treatment planning in castrate-resistant prostate cancer metastatic to bone
    Denis-Bacelar, A. M.
    Divoli, A.
    Chittenden, S.
    Du, Y.
    Dearnaley, D. P.
    O'Sullivan, J. M.
    Frisch, K. J.
    Flux, G. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S271 - S271
  • [28] The New Standard: Personalised Information about the Risks and Benefits of Treatment Strategies for Localised Prostate Cancer
    van Stam, Marie-Anne
    van der Poel, Henk
    EUROPEAN UROLOGY, 2018, 74 (01) : 34 - 36
  • [29] Personalised treatment for cancer: role of biomarkers
    Michael J Duffy
    EPMA Journal, 2014, 5 (Suppl 1):
  • [30] Molecular imaging for personalised treatment of cancer
    Oyen, W. J. G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S19 - S19
12345